All Articles on Obesity
Gastric bypass surgery beats intensive lifestyle and medical intervention for diabetesDr. David Arterburn reflects on CROSSROADS randomized controlled trial of Group Health patients with obesity and type 2 diabetes.
Weight controlled better with bupropion (Wellbutrin) than with other antidepressantsDr. David Arterburn describes his research on Group Health patients’ weight after 2 years on various antidepressants
One antidepressant shown to control weight during 2-year studyResearch at Kaiser Permanente points to bupropion (Wellbutrin) as first choice for overweight and obese patients with depression.
What if a street map could show how healthily people eat?UW and GHRI researchers have come up with innovative maps that illustrate the link between wealth accumulation and diet quality.
Bariatric surgery pros & cons—Why Group Health research mattersDr. David Arterburn talks about his studies with Kaiser and other systems to help a rapidly increasing population with severe obesity.
News release: PCORI approves Group Health for $4.5 million obesity studyStudy leader Dr. David Arterburn will use PCORnet, new national clinical research network, to speed results.
PCORI approves Group Health for $4.5 million obesity studyStudy leader Dr. David Arterburn will use PCORnet, new national clinical research network, to speed results.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.